Science
The Science of ExoTherapy
NurExone’s scientific foundation is built on the study of extracellular vesicles as natural biological messengers and delivery vehicles. Preclinical research has shown that MSC-derived exosomes may interact with damaged neural tissue and support regenerative processes relevant to central nervous system injury.
NurExone pursues strategic collaborations, licensing opportunities, and development partnerships to expand the potential of its ExoTherapy platform beyond its lead therapeutic programs. These relationships may support additional indications, complementary delivery technologies, scalable manufacturing capabilities, and broader regenerative medicine applications.
EVs “Homing” To Damaged Tissue in Laboratory Animal Brain Models
Preclinical imaging studies suggest that extracellular vesicles may accumulate in damaged neural tissue, supporting their potential use as targeted biological delivery vehicles for nervous system injury.
Intranasal MSC-Exosomes Home Specifically To Spinal Cord Lesion
